86
Participants
Start Date
January 28, 2013
Primary Completion Date
March 13, 2015
Study Completion Date
March 13, 2015
Immune Globulin Intravenous (Human), 10% Solution
Intravenous infusion with IGIV, 10%
Immune Globulin Subcutaneous (Human), 20% Solution
Subcutaneous infusion with IGSC, 20%
Montefiore Medical Center Division of Allergy/Immunology, The Bronx
Emory University, Atlanta
Allergy Associates of the Palm Beaches, North Palm Beach
Family Allergy and Asthma Research Institute, Louisville
Medical College of Wisconsin, Milwaukee
Midwest Immunology Clinical and Infusion Center, Plymouth
Rush University Medical Center, Chicago
SSM Cardinal Glennon Children's Medical Center, St Louis
Children's Hospital New Orleans- LSUHSC School of Medicine, New Orleans
Oklahoma Institute of Allergy and Asthma Clinical Research, Oklahoma City
Vital Prospects Clinical Research Institute, PC, Tulsa
Allergy Asthma and Immunology Clinic PA, Irving
Dallas Allergy Immunology Research, Dallas
IMMUNOe International Research Centers, Centennial
Rocky Mountain Asthma/Allergy/Immunology, Layton
University of California, Irvine, Irvine
Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal
Montreal Children's Hospital- McGill University health Center, Montreal
Baxalta now part of Shire
INDUSTRY